EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia

Kyle H Richardson iD, Jessica E Parker iD, Fabrizio Pin

Cells · 01.08.2026 · 15 (15) · 1397

DOI: 10.3390/cells15151397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 01.08.2026. Verfasst von Kyle H Richardson und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Indiana University, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Cachexia, Osteoporosis, Neoplasms, Bone and Bones. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia (CC) is a devastating, multi-organ syndrome historically defined by the progressive wasting of skeletal muscle and adipose tissue. However, emerging evidence suggests that the skeletal system is also a major, yet underappreciated target of this catabolic state. While bone loss in oncology is primarily attributed to skeletal metastasis or cancer treatment-induced bone loss (CTIBL), clinical and preclinical data has increasingly demonstrated that tumor and host-derived systemic signals can drive severe bone deterioration even in non-metastatic disease. This review synthesizes current information available on bone loss, osteopenia, and skeletal decline in the context of CC, with a specific focus on non-metastatic disease. By examining the available literature, we argue that bone loss is a “hidden” yet fundamental systemic manifestation of the cachectic state. Furthermore, we aim to highlight how concurrent muscle and bone deterioration (osteosarcopenia) dramatically worsens prognosis in several different cancers in both the adult and pediatric populations. Ultimately, this review highlights the potential contribution of cancer cachexia to osteoporosis and skeletal fragility, supporting the need for greater clinical awareness, improved musculoskeletal screening, and the development of targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaOsteoporosisNeoplasmsBone and BonesHumansAnimals

Stichwörter der Autor:innen

BMDbone losscancer cachexiafracture riskosteoporosis

Autor:innen und Institutionen

  • School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
  • Department of Anatomy, Cell Biology and Physiology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
  • Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, School of Medicine, Indianapolis, IN 46202, USA.
  • Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN 46202, USA.
  • Indiana Center for Musculoskeletal Health, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.

ORCID-Profile: Kyle H Richardson, Jessica E Parker

Zitieren

APA

Richardson, K. H., Parker, J. E., & Pin, F. (2026). Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia. Cells, 15(15), 1397. https://doi.org/10.3390/cells15151397

Vancouver

Richardson KH, Parker JE, Pin F. Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia. Cells. 2026;15(15):1397. doi:10.3390/cells15151397

BibTeX
@article{Richardson2026,
  author = {Richardson, Kyle H and Parker, Jessica E and Pin, Fabrizio},
  title = {Bone Loss, Osteoporosis, and Skeletal Fragility: Hidden Consequences of Cancer Cachexia},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {1397},
  doi = {10.3390/cells15151397}
}
Kostenlos starten →